Diana Brainard, CEO: Kalaris Therapeutics KLRS Sell · Filed 23/01/23

Trade details

Type: Insider sale
Amount: $174,929.8
Shares · price: 34,435 sh · $5.08 a share
Held after: 601,607 sh
Stock: Kalaris Therapeutics KLRS
Person: Diana BrainardCEO
Trade date: 23/01/19
Filed: 23/01/23
Days to filing: 4 days

Sold 5.4% of holdings

Share of holding sold: 5.4%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/20~23/02/18

Diana Brainard's recent trades

Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$4,788
8,706 sh
$4,788
Filed 24/11/20
Traded 24/11/19
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$9,124
10,609 sh
$9,124
Filed 24/11/06
Traded 24/11/05
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$7,607
9,752 sh
$7,607
Filed 24/10/23
Traded 24/10/21
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$1,209
1,493 sh
$1,209
Filed 24/10/04
Traded 24/10/03
Diana BrainardCEO
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$3,989
5,390 sh
$3,989
Filed 24/08/22
Traded 24/08/20